JULY 2, 2024 by Peter MacCallum Cancer Centre The efficiency of PspCas13b silencing is highly variable between crRNAs. Credit: Nature Structural & Molecular Biology (2024). DOI: 10.1038/s41594-024-01336-0Peter Mac researchers have taken the first step towards designing rapid personalized cancer treatments by ‘cutting out’ disease-causing RNA. The findings, published in Nature Structural & Molecular Biology, demonstrate...